1 January 2022 v2024.4.1 limited_company_frs_102_section_1a_v1_1_0 companies_houseSoftwarefalsetruetruetrueNo description of principal activity00truexbrli:purexbrli:sharesiso4217:GBP098876762022-01-012022-12-31098876762022-12-31098876762021-12-3109887676core:WithinOneYear2022-12-3109887676core:WithinOneYear2021-12-3109887676core:ShareCapital2022-12-3109887676core:ShareCapital2021-12-3109887676core:RetainedEarningsAccumulatedLosses2022-12-3109887676core:RetainedEarningsAccumulatedLosses2021-12-3109887676bus:Director12022-01-012022-12-3109887676bus:RegisteredOffice2022-01-012022-12-3109887676core:CostValuation2022-01-0109887676core:CostValuation2022-12-310988767612022-01-012022-12-31098876762021-01-012021-12-3109887676countries:EnglandWales2022-01-012022-12-3109887676bus:AuditExempt-NoAccountantsReport2022-01-012022-12-3109887676bus:PrivateLimitedCompanyLtd2022-01-012022-12-3109887676bus:SmallEntities2022-01-012022-12-3109887676bus:FullAccounts2022-01-012022-12-31
Company registration number:
09887676
EffeHold Limited
Unaudited Filleted Financial Statements for the year ended
31 December 2022
EffeHold Limited
Report to the board of directors on the preparation of the unaudited statutory financial statements of EffeHold Limited
Year ended
31 December 2022
As described on the statement of financial position, the Board of Directors of
EffeHold Limited
are responsible for the preparation of the
financial statements
for the year ended
31 December 2022
, which comprise the income statement, statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006.
In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
EFFEUK LTD
17 Grosvenor Street,
Mayfair
London
W1K 4QG
United Kingdom
EffeHold Limited
Statement of Financial Position
31 December 2022
20222021
Note££
Fixed assets    
Investments 5
3,095,754
 
3,095,754
 
Current assets    
Debtors 6
64,666
 
62,626
 
Investments 7
3,541,727
  -  
Cash at bank and in hand
218,463
 
3,382,605
 
3,824,856
 
3,445,231
 
Creditors: amounts falling due within one year 8
(29,315
)
(23,141
)
Net current assets
3,795,541
 
3,422,090
 
Total assets less current liabilities 6,891,295   6,517,844  
Capital and reserves    
Called up share capital
1,000
 
1,000
 
Profit and loss account
6,890,295
 
6,516,844
 
Shareholders funds
6,891,295
 
6,517,844
 
For the year ending
31 December 2022
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
31 December 2023
, and are signed on behalf of the board by:
Mr Flavio Girolami
Director
Company registration number:
09887676
EffeHold Limited
Notes to the Financial Statements
Year ended
31 December 2022

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
17 Grosvenor Street
,
London
,
W1K 4QG
, United Kingdom.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Fixed asset investments

Investments in subsidiaries, associates and joint ventures accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses.
Investments in subsidiaries, associates and joint ventures accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income or profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted.
Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Other fixed asset investments which are listed are measured at fair value with changes in fair value being recognised in profit or loss.
All other Investments held as fixed assets are initially recorded at cost, and are subsequently stated at cost less any accumulated impairment losses.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4 Average number of employees

The average number of persons employed by the company during the year was Nil (2021: Nil).

5 Investments

Other investments other than loans
£
Cost  
At
1 January 2022
3,095,754
 
At
31 December 2022
3,095,754
 
Impairment  
At
1 January 2022
and
31 December 2022
-  
Carrying amount  
At
31 December 2022
3,095,754
 
At 31 December 2021
3,095,754
 
The investments are as follows:
- 100& of the ordinary shares of Common Project Srl, a company incorporated in Italy. Share capital: EUR 3,600,000.00.
- 50% of the ordinary shares of Inveffe Ltd, a company incorporated in England and Wales. Share capital: GBP 500,00.
- 100% of the ordinary shares of Effeuk Ltd, a company incorporated in England and Wales. Share capital: GBP 1.00.
- 22% of the ordinary shares of Neurotouch Inc, a company incorporated in Delaware (USA). Share capital USD 1,083.00.

6 Debtors

20222021
££
Other debtors
64,666
 
62,626
 

7 Investments

20222021
££
Other current asset investments
3,541,727
  -  

8 Creditors: amounts falling due within one year

20222021
££
Amounts owed to group undertakings and undertakings in which the company has a participating interest
21,141
 
21,141
 
Other creditors
8,174
 
2,000
 
29,315
 
23,141